Research Figures
Data from the Scientific Report 2022
- 525 Projects
- 406 Clinical Trials
- 816 Publications
- 5563 Total Impact Factor
News
Bellvitge and Sant Joan de Déu identify the genetic variants associated with the most severe forms of Stargardt’s disease
Stargardt's disease is a rare disease that causes the loss of central vision, progressively and irreversibly. It is usually diagnosed before the age of 20 and it is very difficult to predict the evolution of patients: some may worsen very quickly while in others the disease progresses slowly.
An international study led by Sant Joan de Déu confirms that GNAO1-RD disease is not degenerative
The study describes for the first time the long-term evolution of disorders related to the GNAO1 gene.
Interviews
Susana Ochoa Güerre
Psychologist, head of the Research Group on Etiopathogenesis and Treatment of Severe Mental Disorders (MERITT) at the Institut de Recerca Sant Joan de Déu (IRSJD) and head of research at the Parc Sanitari Sant Joan de Déu (PSSJD).
Agenda
Seminari Científic Extraordinari IRSJD: Known, Unknown, Unknowable: Redefining the Edge of Biotech & Digital Health
El Institut de Recerca Sant Joan de Déu reanuda su tradicional Ciclo de Seminarios Científicos del IRSJD, una actividad que durante años ha sido un espacio clave de encuentro, intercambio y debate para toda la comunidad investigadora del centro.